Financhill
Sell
30

ZYME Quote, Financials, Valuation and Earnings

Last price:
$12.56
Seasonality move :
14.48%
Day range:
$12.23 - $13.17
52-week range:
$7.97 - $17.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.18x
P/B ratio:
2.52x
Volume:
577.8K
Avg. volume:
568.9K
1-year change:
13.74%
Market cap:
$852.3M
Revenue:
$76.3M
EPS (TTM):
-$1.61

Earnings Data

Next earnings date for ZYME
May 02
2025
Most recent earnings per share
-$0.31
Missed by $0.22
(Mar 5/2025)
Consensus Estimate
-$0.09
(Mar 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ZYME Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/02/2025 Q1 $20.7M -- -- -$0.74 --
03/05/2025 Q4 $45.2M $31M -$0.31 -$0.09 -$0.22
10/31/2024 Q3 $17.9M $16M -$0.39 -$0.41 $0.02
08/01/2024 Q2 $20.1M $19.2M -$0.49 -$0.31 -$0.18
05/02/2024 Q1 $16.7M $10M -$0.42 -$0.29 -$0.13
03/06/2024 Q4 $17.7M $16.9M -$0.19 -$0.44 $0.25
11/07/2023 Q3 -- -- -$0.41 -$0.47 $0.06
08/10/2023 Q2 -- -- -$0.76 -$0.47 -$0.29
05/08/2023 Q1 -- -- -$0.37 -$0.54 $0.17
03/07/2023 Q4 -- -- $4.65 $3.11 $1.54
11/08/2022 Q3 -- -- -$0.72 -$0.97 $0.25
08/04/2022 Q2 -- -- -$0.97 -$0.94 -$0.03
05/04/2022 Q1 -- -- -$1.19 -$0.76 -$0.43
02/24/2022 Q4 -- -- -$0.95 -$1.13 $0.18
11/03/2021 Q3 -- -- -$1.25 -$1.08 -$0.17
08/04/2021 Q2 -- -- -$1.31 -$1.04 -$0.27
05/05/2021 Q1 -- -- -$0.87 -$1.03 $0.16
02/24/2021 Q4 -- -- -$0.74 -$1.25 $0.51
11/03/2020 Q3 -- -- -$1.43 -$0.99 -$0.44
08/05/2020 Q2 -- -- -$0.77 -$0.87 $0.10
05/07/2020 Q1 -- -- -$0.64 -$1.04 $0.40
03/02/2020 Q4 -- -- -$1.66 -$0.88 -$0.78
11/05/2019 Q3 -- -- -$0.70 -$0.74 $0.04
08/02/2019 Q2 -- -- -$0.86 -$0.60 -$0.26
05/02/2019 Q1 -- -- -$0.43 -$0.52 $0.09
03/06/2019 Q4 -- -- $0.29 $0.53 -$0.24
11/06/2018 Q3 -- -- -$0.59 -$0.64 $0.05
08/01/2018 Q2 -- -- -$0.22 -$0.33 $0.11
05/01/2018 Q1 -- -- -$0.83 -$0.67 -$0.16
12/31/2017 Q4 -- -- $1.28 -$0.03 $1.31
09/30/2017 Q3 -- -- -$0.64 -$0.57 -$0.07
08/08/2017 Q2 -- -- -$0.38 -$0.54 $0.16

Zymeworks Earnings Questions

  • How Much did Zymeworks Generate in Revenue Last Quarter?

    Zymeworks reported $31M worth of top line sales in its most recent quarter.

  • Did Zymeworks Beat Earnings Last Quarter?

    Zymeworks announced earnings per share of -$0.31 which represents a miss of analyst forecast a -$0.09 per share.

  • Is Zymeworks Profitable?

    Zymeworks reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Zymeworks EPS Next Year?

    Zymeworks's earnings are forecast to decrease from -$1.62 per share to -$1.44 per share next year representing a decrease of -6.39%.

  • When is Zymeworks's Earnings Date?

    Zymeworks's next earnings date is May 2, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Is Ford Stock Undervalued Amid the EV Transition?
Is Ford Stock Undervalued Amid the EV Transition?

There is a lot going on in the electric vehicle…

Is Goldman Sachs Stock a Buy Sell or Hold?
Is Goldman Sachs Stock a Buy Sell or Hold?

When the Federal Reserve started hiking rates in 2022, banks’…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
49
SMTC alert for Mar 17

Semtech [SMTC] is down 0.49% over the past day.

Buy
62
PLPC alert for Mar 17

Preformed Line Products [PLPC] is up 3.8% over the past day.

Sell
50
NUTX alert for Mar 17

Nutex Health [NUTX] is up 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock